The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency

Clinical trial NCT06046820 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06046820
Sponsor: Inozyme Pharma
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency Autosomal Recessive Hypophosphatemic Rickets Generalized Arterial Calcification of Infancy

Start date: 2023-11-05
Primary completion: 2026-01-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.